Insight Molecular Diagnostics Inc. (IMDX) earnings
IMDX earnings moved a median of -0.06% by the close. Quarterly and annual IMDX reports and results, each read against the price at its own news timestamp. Back to the IMDX overview →
14 measured IMDX earnings events.
Where these IMDX earnings landedvs 12 measured IMDX earnings reactions
| Middle 50% of IMDX earnings reactions | -4.03% to +13.16% |
|---|---|
| Median reaction (to close) | -0.06% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 IMDX earnings events with a measured close landed between -4.03% and +13.16%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| iMDx to Release Third Quarter Results on November 16, 2026 | Press release | -1.91% | -6.11% | |
| iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference | Press release | +1.76% | +0.20% | |
| Form 10-Q Insight Molecular Diagno For: Mar 31 | SEC filing · Form 10-Q | +8.74% | +30.49% | |
| IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization | Press release | +8.74% | +30.49% | |
| iMDx to Release First Quarter 2026 Results on May 13, 2026 | Press release | +1.40% | -1.00% | |
| Form 10-K Insight Molecular Diagno For: Dec 31 | SEC filing · Form 10-K | -3.96% | -14.63% | |
| IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results | Press release | -3.96% | -14.63% | |
| iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference | Press release | +0.00% | +4.93% | |
| Form 10-Q Insight Molecular Diagno For: Sep 30 | SEC filing · Form 10-Q | -2.26% | +13.16% | |
| IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch | Press release | -2.26% | +13.16% | |
| iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week | Press release | -5.69% | -0.33% | |
| Form 10-Q Insight Molecular Diagno For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch | Press release | +0.00% | — | |
| iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference | Press release | +5.18% | -3.33% |
Keep exploring
More IMDX: analyst actions → · SEC filings → · IMDX overview →